Balaxi Pharmaceuticals Ltd Annually Results

Gross Sales

241.29

336.43

279.39

231.33

45.63

Excise Duty

0

0

0

0

0

Net Sales

241.29

336.43

279.39

231.33

45.63

Other Operating Income

0

0

0

0

0

Other Income

-2.65

2.64

4.97

2.23

0.59

Total Income

238.65

339.07

284.36

233.56

46.23

Total Expenditure

194.56

279.89

229.18

188.92

37.44

PBIDT

44.08

59.17

55.18

44.64

8.79

Interest

1.68

0.5

0.14

0.01

0

PBDT

42.41

58.67

55.03

44.63

8.79

Depreciation

2.1

1.75

0.51

0.3

0.01

Minority Interest Before NP

0

0

0

0

0

Tax

4.51

9.9

6.83

6.19

2.68

Deferred Tax

-0.11

1.06

0.03

0

0

Reported Profit After Tax

35.91

45.96

47.66

38.14

6.1

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

35.91

45.96

47.66

38.14

6.1

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

35.91

45.96

47.66

38.14

6.1

EPS (Unit Curr.)

-2.32

45.81

47.66

38.14

8.12

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

5

0

0

Equity

10.9

10.18

10

10

10

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

18.26

17.58

19.75

19.29

19.26

PBDTM(%)

17.57

17.43

19.69

19.29

19.26

PATM(%)

14.88

13.66

17.05

16.48

13.36